1 | Less than $15 |
2 | $15 to $53 |
3 | $54 to $99 |
4 | $100 to $299 |
5 | $300 to $999 |
6 | $1000 or over |
7 | no data |
1 | 91%-100% |
2 | 75%-89% |
3 | 50%-74% |
4 | 25%-49% |
5 | 5%-24% |
6 | 0.1%-5% |
Links
Links
General Government Expenditure on Health Per Capita expressed in PPP international Dollars
![](/global/resources/images/ahs-indicator-arrows-bright.png)
What does it mean ?
This indicator shows how much of the government's own resources are allocated to health per person. It is expressed in Purchasing Power Parity (PPP) international dollars. PPP is a hypothetical exchange rate that allows us to compare expenditure across countries while taking into account differences in the cost of living.
Why does it matter ?
This indicator can tell us whether a government spends enough of its own resources on health per person in order to guarantee universal coverage of essential services, particularly for vulnerable groups such as the poor, pregnant women and children. Universal coverage is unlikely to be achieved unless the government allocates sufficient funds to health so that everybody can access the health services they need regardless of their ability to pay. While other funding sources such as donor funds can also make an important contribution to the provision of equitable services, these funds may not be spent according to the country's priorities and may not provide a reliable source of funding in the long-term. There is no consensus on how much funding a government should allocate to health since different countries will have different needs and different contexts. However 54 (PPP) international dollars is often used as a benchmark - for example, this is the minimum amount required to achieve the health MDGs according to the 2010 Taskforce on Innovative International Financing for Health Systems.
How is it collected ?
The preferred source of data for this indicator is a National Health Account, which is an internationally agreed method for collecting information about all financial flows related to health in a country. Where a recent National Health Account is not available, the WHO's health financing team collects similar information using technical contacts in-country and publicly available documents.
2014 WHO World Health Statistics Report http://apps.who.int/nha/database
Female Genital Mutilation / Cutting in Africa
![](/global/resources/images/ahs-indicator-arrows-bright.png)
What does it mean ?
Female Genital Mutilation / Cutting (FGM / C) refers to all procedures involving partial or total removal of the female external genitalia or other injury to the female genital organs for non-medical reasons. Prevalence of FGM / C is the percentage of all women aged 15-49 years who have undergone FGM.
Why does it matter ?
FGM / C is a violation of the rights of girls and women and is considered a form of gender-based violence. It is associated with serious adverse short and long term health consequences including pain, bleeding, infection and birth complications. Data on the practice is needed to evaluate the impact of policies and legislation and monitor progress toward elimination, which is included as a target for Sustainable Development Goal 5: to achieve gender equality and empower all women and girls. Target 5.3: by 2030 "eliminate all harmful practices, such as early, forced and child marriage, and female genital mutilation."
How is it collected ?
Most data on FGM / C is self-reported and collected retrospectively from large scale, nationally representative surveys such as Demographic and Health (DHS) or Multiple Indicator Cluster Surveys (MICS).
Unicef datasets most recent available data
http://data.unicef.org/child-protection/fgmc.html Accessed 15th August 2016